Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Buy Out

<< Previous

Bullboard Posts

Next >>

Comment by Redbaron2211on Apr 10, 2021 1:25pm

139 Views

Post# 32972870

RE:RE:RE:RE:Buy Out

It's speculation but nothing out of the realm of possibilities. Sure didn't expect Semma getting taken out like that. Big pharma is starting to positioning for RM and mergers/acquisitions will continue to pick up. Sernova sticks out as a target as the bottle neck isn't in the cell lines.

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"